Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 121
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Do dietary supplements extend lifespan and prevent brain disease?

Can a cheap, over the counter pill, prevent the onset of ageing-related diseases and extend lifespan? I...

Managing Congenital Adrenal Hyperplasia in the Amish Population

Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...

Making Inexpensive Insulin Using Microalgae

This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...

Backer Badge Funded